Comparative study of the antioxidant properties of rutin and quercetin in the chemical in vitro dopamine oxidation system
Farmatsevtychnyi zhurnal · 28.04.2026 · (2) · 77-87
DOI: 10.32352/0367-3057.2.26.07 ↗Kurz gefasst
Fachartikel in der Zeitschrift Farmatsevtychnyi zhurnal, online erschienen am 28.04.2026. Verfasst von V. V. Udovytskyi und 1 weiteren Autor:innen. Die Arbeit nennt 20 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
It is believed that one of the key pathogenetic mechanisms of Parkinson's disease is oxidative stress, during which free radicals not only damage cellular structures but also provoke the oxidation of the neurotransmitter dopamine, which is responsible for regulating motor functions. This process also leads to the formation of toxic metabolites, which, in turn, enhance neurodegeneration. This determines the relevance of the search for antioxidants that can be included in pharmaceutical compositions for use in complex pharmacotherapy of Parkinson's disease in order to reduce oxidative damage to dopamine. The flavonoids rutin and quercetin are promising candidates due to their antioxidant properties, however, a comparative assessment of their effectiveness in inhibiting dopamine oxidation is necessary. The aim of the work was to compare the antioxidant properties of rutin and quercetin in a model chemical in vitro system of dopamine oxidation. The effect of rutin and quercetin on the process of dopamine oxidation in a model chemical in vitro system was studied spectrophotometrically at final concentrations in the reaction mixture of 50, 100 and 200 μM. Trolox was used as a reference antioxidant in similar concentrations. The quantitative expression of reaction rates was carried out by calculating the first-order rate constant. For the first time, the effect of flavonoid compounds, namely rutin and quercetin, as well as trolox on the process of dopamine oxidation in a model in vitro system was studied. It was proven that all the studied compounds inhibit the oxidation of the neurotransmitter, and their effect has a pronounced dose-dependent nature. It was found that at a final concentration of 200 μM, quercetin and rutin reduce the rate constant of dopamine oxidation by 1.67 and 2.20 times, respectively. In contrast, trolox, used as a reference antioxidant, demonstrated a better effect at a similar concentration, reducing the rate of dopamine oxidation by 2.53 times. The results of the study confirm the prospect of using the flavonoids rutin and quercetin, as well as trolox as adjuvants and components of pharmaceutical compositions for combined pharmacotherapy and prevention of Parkinson's disease, reducing the progression of the disease by slowing the rate of dopamine oxidation.
Zitieren
APA
Udovytskyi, V. V., & Bessarabov, V. I. (2026). Comparative study of the antioxidant properties of rutin and quercetin in the chemical in vitro dopamine oxidation system. Farmatsevtychnyi zhurnal, 77-87. https://doi.org/10.32352/0367-3057.2.26.07
Vancouver
Udovytskyi VV, Bessarabov VI. Comparative study of the antioxidant properties of rutin and quercetin in the chemical in vitro dopamine oxidation system. Farmatsevtychnyi zhurnal. 2026:77-87. doi:10.32352/0367-3057.2.26.07
BibTeX
@article{Udovytskyi2026,
author = {Udovytskyi, V. V. and Bessarabov, V. I.},
title = {Comparative study of the antioxidant properties of rutin and quercetin in the chemical in vitro dopamine oxidation system},
journal = {Farmatsevtychnyi zhurnal},
year = {2026},
number = {2},
pages = {77--87},
doi = {10.32352/0367-3057.2.26.07}
}
EUVIMED